ask="N/A"
ask_size="N/A"
average_daily_volume="1225150"
bid="43.45"
bid_size="700"
book_value="11.83"
change="+0.61"
change_from_200_day_moving_average="-6.77"
change_from_50_day_moving_average="5.15"
change_from_52_week_high="-34.54"
change_From_52_week_low="14.19"
change_in_percent="+1.36%"
close="45.57"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.88"
eps_estimate_next_quarter="-1.27"
eps_estimate_next_year="-4.60"
ex_dividend_date="N/A"
float_shares="70877000"
high="46.20"
high_52_weeks="80.11"
last_trade_date="2/10/2017"
last_trade_price="45.57"
last_trade_size="25155"
last_trade_time="4:00pm"
low="44.56"
low_52_weeks="31.38"
market_capitalization="3.91B"
moving_average_200_day="52.34"
moving_average_50_day="40.42"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="45.00"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-12.93%"
percent_change_from_50_day_moving_average="+12.73%"
percent_change_from_52_week_high="-43.12%"
percent_change_from_52_week_low="+45.22%"
previous_close="44.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.80"
price_per_sales="103.56"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="646289"
weeks_range_52="31.38 - 80.11"
